Clinical Trials Sponsored by Xenios AG

Total 2555 results

Assistance Publique - Hôpitaux de Paris
Xenios AG

Recruiting

Effects of Blood Pulsatility on Von Willebrand Factor During ECCO2R (FLOW-ECCO2R)

Acute Respiratory Distress Syndrome | Pulmonary Disease | Extracorporeal CO2 Removal | Chronic Obstructive Pulmonary Disease Exacerbation

France
Xenios AG

Not yet recruiting

Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients (PulseSE)

Extracorporeal Membrane Oxygenation | Cardiogenic Shock | ECLS | VA ECMO

Germany
Xenios AG
MAXIS Medical

Completed

Synchronized Cardiac Assist for Cardiogenic Shock

Shock, Cardiogenic | High Risk Percutaneous Coronary Interventions

Germany
Xenios AG
Winicker Norimed GmbH

Recruiting

Early Extubation by ECCO2R Compared to IMV in Patients With Severe Acute Exacerbation of COPD (X-COPD)

COPD Exacerbation

Germany
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; Xenios AG

Recruiting

CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases (CORAIL)

COPD Acute Exacerbation

France
Xenikos

Completed

Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD

Graft vs Host Disease

Netherlands, Germany
Xencor, Inc.

Recruiting

Phase 1, Safety and Tolerability Study of XmAb®541 in Advanced Solid Tumors

Testicular Germ Cell Tumor | Ovarian Cancer | Endometrial Cancer | Ovarian Germ Cell Tumor | Germ Cell Tumor

United States
Xencor, Inc.

Recruiting

Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis

Psoriasis | Atopic Dermatitis

United States
Xencor, Inc.

Recruiting

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Clear Cell Renal Cell Carcinoma

United States
Geneos Therapeutics

Active, not recruiting

GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC

HCC

United States, New Zealand
Xencor, Inc.

Terminated

Study Evaluating AMG 424 in Subjects With Multiple Myeloma

Relapsed/ Refractory Multiple Myeloma

United States, Australia
Xencor, Inc.

Completed

Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis

Allergic Rhinitis | Atopic Dermatitis | Allergic Conjunctivitis

United States
Xention Ltd

Completed

Bioequivalence Study of Capsule and Tablet Formulations of TA-8995

Dyslipidaemia

United Kingdom
Xention Ltd

Completed

TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP) (TULIP)

Dyslipidemia

Denmark, Netherlands
Xencor, Inc.

Recruiting

Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC

Nonsquamous Non-small Cell Lung Cancer

United States
Xencor, Inc.

Recruiting

A Study of XmAb®662 as Monotherapy or in Combination With Pembrolizumab in Advanced Solid Tumors

Solid Tumors

United States
Quit Genius

Recruiting

RCT of an Integrated Digital Intervention for Alcohol Use Disorder (Alcohol RCT)

Alcohol Use Disorder

United States
Xencor, Inc.

Recruiting

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Colorectal Cancer | Castration-resistant Prostate Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Ovarian Cancer, Epithelial | TNBC - Triple-Negative Breast Cancer | Renal Cell Carcinoma, Clear Cell | Melanoma Excluding Uveal Melanoma | Non-small Cell Lung Cancer, Squamous or...

United States
Xencor, Inc.

Recruiting

XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer

United States
Xention Ltd

Completed

A Preliminary Drug Drug Interaction Study With TA-8995

Pharmacokinetic Interactions

United Kingdom
Xention Ltd

Completed

A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)

Elevated Lp(a)

Denmark
Xencor, Inc.

Completed

Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma

Hodgkin Lymphoma | Anaplastic Large Cell Lymphoma

United States
Xencor, Inc.

Completed

Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Bottneuro AG
Hemex AG

Active, not recruiting

Evaluate the Safety and Feasibility of tACS With the Miamind Neurostimulator in Healthy Participants (MindStim)

Healthy Participants | Healthy Population

Switzerland
Tetec AG
Aesculap AG

Completed

Non-Interventional Study to Evaluate Safety and Efficacy of NOVOCART 3D in Patients With Cartilage Defects (NISANIK)

Cartilage Diseases

Germany
Santersus AG
ISS AG

Not yet recruiting

Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating cfDNA/NETs in Subjects With Sepsis (NUC-CAP)

Sepsis | Respiratory Failure

United Kingdom, Germany, Switzerland
SynDermix AG
ISS AG

Withdrawn

Safety and Efficacy of SDX-3101 for the Treatment of Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) (SDX-3101)

Chronic Rhinosinusitis Without Nasal Polyps

Germany, Austria, Switzerland
Tetec AG
Aesculap AG

Completed

Observational Study With NOVOCART® Inject in the Reconstruction of the Hip Joint With Full Thickness Cartilage Defects (HIP-ACTION)

Cartilage Disease

Germany
Xencor, Inc.

Terminated

Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in R/R DLBCL

Diffuse Large-cell B-cell Lymphoma

Spain, United States, France
Xention Ltd

Completed

ADME Study in Healthy Male Subjects With TA-8995

Dyslipidemia

United Kingdom
Xention Ltd

Completed

Fed-Fasted, Single and Multiple Ascending Dose Trial of XEN-D0103

Atrial Fibrillation

United Kingdom
Xention Ltd

Completed

Study of the Electrocardiographic Effects of TA-8995

Dyslipidaemia

United Kingdom
Helios Klinik Gotha/Ohrdruf
Helios Klinikum Erfurt

Not yet recruiting

Outcomes of Patient Blood Management in Severely Anemic Patients

Severe Anemia

Germany
Spiden AG
DCB Research AG

Recruiting

A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults With Type-1 Diabetes Mellitus

Type 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With Hyperglycemia

Switzerland
iOMEDICO AG
Roche Pharma AG

Active, not recruiting

Registry for Molecular Testing, Treatment and Outcome of Patients With Solid Tumors Harboring a NTRK Gene Fusion (REALTRK)

NTRK Family Gene Mutation

Switzerland, Germany
iOMEDICO AG
Roche Pharma AG

Completed

Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy (CHAPLIN)

Extensive-stage Small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC

Germany
Helios Klinikum Pforzheim

Recruiting

Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair

Right Heart Failure | Tricuspid Regurgitation | Cardiac Remodeling, Ventricular | Cardiac Remodeling, Atrial

Germany
Prevent Senior Institute

Completed

Evaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for Breast Cancer

Breast Cancer Female

Brazil
Helios Research Center

Completed

Surgical Treatment of Hip Fractures Under Peripheral Regional Anesthesia

Hip Fractures

Germany
Helios Research Center

Completed

Ultrasound-guided Intermediate Cervical Plexus Block

Internal Carotid Artery Stenosis

Germany
Helios Research Center

Completed

Ultrasound Guided Distal Sciatic Nerve Block - a Comparison With Nerve Stimulator Technique

Other Surgical Procedures
Telios Pharma, Inc.

Recruiting

A Study Of TL-925 For The Treatment of AC

Allergic Conjunctivitis

United States
Telios Pharma, Inc.

Recruiting

A Study of TL-925 for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Xencor, Inc.
Parexel

Completed

XmAb5871 Bioavailability Study

Healthy Volunteers

United States
Helios Research Center

Completed

Ultrasound Guided Intermediate Cervical Plexus Block and Additional Perivascular Local Anesthetic Infiltration

Carotid Stenosis
Helios Salud
Abbott

Unknown

Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen

Dyslipidemia | HIV | Hypercholesterolemia

Argentina
Helios Research Center

Completed

Ultrasound-guided Axillary Plexus Block - Dose Reduction of Prilocaine

Other Surgical Procedures
Swiss Medical Food AG
iOMEDICO AG

Completed

Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy (STEFANO)

CIPN in Adjuvant Colon Cancer Patients | CIPN in Adjuvant Breast Cancer Patients

Germany
Xeris Pharmaceuticals

Completed

Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Diabetes Mellitus, Type 1 | Insulin-dependent Diabetes Mellitus

United States
Telios Pharma, Inc.

Recruiting

A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease

Dry Eye Disease

United States

Clinical Trials Sponsored by Xenios AG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations